Westport Resources Management’s Alaunos Therapeutics TCRT Stock Holding History

Westport Resources Management’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$245K	Buy	290 +7	+2%	+$5.63K	0.18%	129
2016 Q2	$233K	Buy	283 +6	+2%	+$6.53K	0.08%	223
2016 Q1	$308K	Buy	277 +79	+40%	+$80.9K	0.1%	185
2015 Q4	$246K	Hold	198	–	–	0.07%	229
2015 Q3	$267K	Buy	198 +7	+4%	+$11.6K	0.08%	224
2015 Q2	$344K	Sell	191 -46	-19%	-$71.4K	0.1%	214
2015 Q1	$382K	Hold	237	–	–	0.1%	212
2014 Q4	$180K	Buy	237 +14	+6%	+$7.43K	0.05%	313
2014 Q3	$88K	Buy	223 +6	+3%	+$2.89K	0.02%	441
2014 Q2	$131K	Buy	217 +14	+7%	+$7.79K	0.04%	373
2014 Q1	$140K	Hold	203	–	–	0.04%	357
2013 Q4	$132K	Buy	203 +103	+103%	+$61.3K	0.04%	354
2013 Q3	$59K	Buy	+100	New	+$45.1K	0.02%	497

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westport Resources Management's TCRT Position: Q3 2016 in Review

Westport Resources Management increased its Alaunos Therapeutics (TCRT) stake by 2.5% in Q3 2016, buying an estimated $5.63K and bringing the position to 290 shares worth $245K. The position accounts for 0.18% of the portfolio, ranked #129.

Westport Resources Management first reported a position in TCRT in Q3 2013 and has held it in 13 quarters since. The position peaked at $382K in Q1 2015. 140 funds tracked by Wall St. Rank hold TCRT as of Q3 2016.

Westport Resources Management held 290 shares of Alaunos Therapeutics worth $245K as of Q3 2016.
Westport Resources Management bought 7 Alaunos Therapeutics shares in Q3 2016, an estimated $5.63K.
Alaunos Therapeutics made up 0.18% of Westport Resources Management's portfolio in Q3 2016, its #129 holding.
Westport Resources Management first reported a position in Alaunos Therapeutics in Q3 2013 and has held it in 13 quarters since.
Westport Resources Management's Alaunos Therapeutics position peaked at $382K in Q1 2015.
140 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.